HO-3867

Catalog No.S7501 Batch:S750101

Print

Technical Data

Formula

C28H30F2N2O2
Molecular Weight 464.55 CAS No. 1172133-28-6
Solubility (25°C)* In vitro DMSO 13 mg/mL (27.98 mM)
Ethanol 6 mg/mL (12.91 mM)
Water Insoluble
In vivo (Add solvents to the product individually and in order)
Homogeneous suspension
CMC-NA
≥5mg/ml Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.
Clear solution
5%DMSO 40%PEG300 5%Tween80 50%ddH2O

Validated by Selleck labs. Should you need adjustments to this formulation, contact our sales team for custom testing.

 0.650mg/ml (1.40mM) Taking the 1 mL working solution as an example, add 50 μL of 13 mg/ml clarified DMSO stock solution to 400 μL of PEG300, mix evenly to clarify it; add 50 μL of Tween80 to the above system, mix evenly to clarify; then continue to add 500 μL of ddH2O to adjust the volume to 1 mL. The mixed solution should be used immediately for optimal results. 
Clear solution
5% DMSO 95% Corn oil

Validated by Selleck labs. Should you need adjustments to this formulation, contact our sales team for custom testing.

 0.330mg/ml (0.71mM) Taking the 1 mL working solution as an example, add 50 μL of 6.6 mg/ml clear DMSO stock solution to 950 μL of corn oil and mix evenly. The mixed solution should be used immediately for optimal results. 
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
* Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

Biological Activity

Description HO-3867, an analog of curcumin, is a selective STAT3 inhibitor that inhibits its phosphorylation, transcription, and DNA binding without affecting the expression of other active STATs. HO-3867 induces apoptosis.
Targets
STAT3 [1]
In vitro HO-3867 produces significant cytotoxicity in A2780 and other tested ovarian cancer cell lines, with less toxic to noncancerous ovarian surface epithelial cells. HO-3867 induces G(2)-M cell cycle arrest in A2780 cells and promotes apoptosis by caspase-8 and caspase-3 activation. HO-3867 blocks the JAK/STAT3 pathway in human ovarian cancer cell lines. [1]
In vivo HO-3867 (100 ppm p.o.) inhibits the growth of ovarian cancer xenograft tumor in mice without any apparent signs of toxicity, and also results in inhibition of pSTAT3 as well as downregulation of the STAT3-targeting proteins. [1] HO-3867 sensitizes cisplatin-resistant ovarian carcinoma through STAT3 inhibition. [2] HO-3867 (100 ppm p.o.) also attenuates left-heart-failure-induced pulmonary hypertension by decreasing oxidative stress and increasing PTEN expression in the lung of rats. [3]

Protocol (from reference)

Cell Assay:

[1]
  • Cell lines

    A2780 (A2780R), PA-1, SKOV3, OV4, and OVCAR3 cells; human ovarian surface epithelial cell

  • Concentrations

    ~20 μM

  • Incubation Time

    24 hours

  • Method

    Cell viability is determined by a colorimetric assay using MTT. In the mitochondria of living cells, yellow MTT undergoes a reductive conversion to formazan, producing a purple color. Cells, grown to ~80% confluence in 75-mm flasks, are trypsinized, counted, seeded in 96-well plates with an average population of 7,000 cells/well, incubated overnight, and then treated with HO-3867 for 24 h. All experiments are done using 8 replicates and repeated at least three times.
Animal Study:

[1]
  • Animal Models

    Mice bearing ovarian cancer A2780 tumor xenografts

  • Dosages

    ~100 ppm

  • Administration

    p.o.

References

  • https://pubmed.ncbi.nlm.nih.gov/2044/
  • https://pubmed.ncbi.nlm.nih.gov/21885917/
  • https://pubmed.ncbi.nlm.nih.gov/23339168/

Customer Product Validation

Cell apoptosis as measured by TUNEL. Representative sections as determined at 12 hours after reperfusion (3100 magnification). Apoptotic nuclei were stained red, and the software of Image J was used to analyse quantity of TUNEL-positive cells in the livers. Scale bars5100 lm. *P<0.05, **P<0.01, ***P<0.001 compared with IR group.

Data from [ , , Liver Transpl, 2016, 22(12):1697-1709 ]

The inhibitory effect of IL-6/IL-6R on TRPM7 currents is blocked by the STAT3 inhibitor HO-3867, but not by the inhibitor MAPK signaling pathway. (A) Relative currents normalized to TRPM7 currents recorded during perfusion with divalent-free extracellular solution. The specific STAT3 inhibitor HO-3867 did not inhibit TRPM7 inward currents at -100 mV, but blocked the effect of IL-6/sIL-6R (n = 3, * p < 0.05 vs. control, # p < 0.05 vs. IL-6/sIL-6R). (B) The specific MAPK−MEK inhibitor PD98059, did not inhibit TRPM7 inward currents at -100 mV, and did not block the effect of IL-6/sIL-6R (n = 3, * p < 0.05 vs. control). All currents were normalized to controls at -100 mV.

Data from [ , , PLOS ONE, 2016, 11(3): e0152120. ]

Inhibition of Stat3 activity on autophagy and hepatic IRI. (A) Pathological analyses showing that inhibition of Stat3 activity increased histopathologic injury in livers subjected to IRI treatment (×200). Scale bars=20μm. And quantified IR-induced liver injury by measuring Suzuki

Data from [ , , J Cell Biochem, 2018, 119(4):3440-3450 ]

Interleukin (IL)-22-mediated protection against sodium nitroprussiate (SNP)-induced apoptosis in fibroblast-like synoviocytes established from rheumatoid arthritis (RA) patients (RA-FLS) is mediated by upregulation of the anti-apoptotic proteins Bcl2 and Bcl-xL. Cells were pretreated with HO-3867 (10 lmol/L) or STA21 (25 lmol/L) 2 h before the addition of IL-22 (100 ng/mL). Cells were then cultured for 30 min prior to the addition of SNP (1.33 mmol/L) and incubation for an additional 24 h. a. Western blot analysis of Bcl-2 protein expression in RA-FLS. A representative Western blot is shown in the left panel. Expression of Bcl-2 was quantified by densitometric analysis (right panel). Data represent the mean SD of three independent experiments. b. Western blot analysis of Bcl-xL in RA-FLS. A representative Western blot is shown in the left panel. Expression of Bcl-xL was quantified by densitometric analysis (right panel). Data represent the mean SD of three independent experiments. Each value is expressed as the ratio of the measured protein level to that of b-actin. *P < 0.05, #P > 0.05 versus control, &P < 0.05 versus SNP, %P < 0.05 versus SNP+ IL-22.

Data from [ , , Int J Rheum Dis, 2017, 20(2):214-224 ]

Selleck's HO-3867 has been cited by 26 publications

BRD7 Inhibited Immune Escape in Nasopharyngeal Carcinoma via Inhibiting PD-L1 Expression [ Int J Biol Sci, 2025, 21(5):1914-1931] PubMed: 40083706
Role of IL-6/STAT3 Axis in Resistance to Cisplatin in Gastric Cancers [ Biomedicines, 2023, 11(3)694] PubMed: 36979673
Curcumin Analog, HO-3867, Induces Both Apoptosis and Ferroptosis via Multiple Mechanisms in NSCLC Cells with Wild-Type p53 [ Evid Based Complement Alternat Med, 2023, 2023:8378581] PubMed: 36814470
The regulation of T helper cell polarization by the diterpenoid fraction of Rhododendron molle based on the JAK/STAT signaling pathway [ Front Pharmacol, 2022, 13:1039441] PubMed: 36386123
The regulation of T helper cell polarization by the diterpenoid fraction of Rhododendron molle based on the JAK/STAT signaling pathway [ Front Pharmacol, 2022, 13:1039441] PubMed: 36386123
Establishment and characterization of immortalized sweat gland myoepithelial cells [ Sci Rep, 2022, 12(1):7] PubMed: 34997030
Tumor Environment Promotes Lnc57Rik-Mediated Suppressive Function of Myeloid-Derived Suppressor Cells [ J Immunol, 2022, 209(7):1401-1413] PubMed: 36038289
IL-27 signalling promotes adipocyte thermogenesis and energy expenditure [ Nature, 2021, 600(7888):314-318] PubMed: 34819664
Gene deficiency or pharmacological inhibition of PDCD4-mediated FGR signaling protects against acute kidney injury [ Acta Pharm Sin B, 2021, 11(2):394-405] PubMed: 33643819
Surfactant protein A modulates the activities of the JAK/STAT pathway in suppressing Th1 and Th17 polarization in murine OVA-induced allergic asthma [ Lab Invest, 2021, 10.1038/s41374-021-00618-1] PubMed: 34108631

RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.

SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.

NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.